150 related articles for article (PubMed ID: 33054434)
1. Short-term societal economic burden of first-incident type 2 diabetes-related complications - a nationwide cohort study.
Kjellberg J; Tikkanen CK; Bagger M; Gæde P
Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):577-586. PubMed ID: 33054434
[TBL] [Abstract][Full Text] [Related]
2. Attributable societal costs of first-incident obesity-related cardiovascular comorbidities in Denmark.
Kjellberg J; Tikkanen CK
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):673-681. PubMed ID: 33794723
[No Abstract] [Full Text] [Related]
3. Costs of diabetes and its complications in Poland.
Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
[TBL] [Abstract][Full Text] [Related]
4. Societal costs of diabetes mellitus in Denmark.
Sortsø C; Green A; Jensen PB; Emneus M
Diabet Med; 2016 Jul; 33(7):877-85. PubMed ID: 26414087
[TBL] [Abstract][Full Text] [Related]
5. Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up.
Chen HY; Kuo S; Su PF; Wu JS; Ou HT
Diabetes Care; 2020 Aug; 43(8):1732-1740. PubMed ID: 32444454
[TBL] [Abstract][Full Text] [Related]
6. Changes in prevalence of diabetic complications and associated healthcare costs during a 10-year follow-up period among a nationwide diabetic cohort.
Chen HL; Hsu WW; Hsiao FY
J Diabetes Complications; 2015; 29(4):523-8. PubMed ID: 25770886
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
Salman RA; AlSayyad AS; Ludwig C
BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
[TBL] [Abstract][Full Text] [Related]
8. Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016.
Vadstrup K; Alulis S; Borsi A; Elkjaer Stallknecht S; Nielsen A; Rikke Jørgensen T; Wennerström C; Qvist N; Munkholm P
Scand J Gastroenterol; 2020 Jan; 55(1):41-46. PubMed ID: 31960726
[No Abstract] [Full Text] [Related]
9. Cost of illness of atrial fibrillation: a nationwide study of societal impact.
Johnsen SP; Dalby LW; Täckström T; Olsen J; Fraschke A
BMC Health Serv Res; 2017 Nov; 17(1):714. PubMed ID: 29126415
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control.
Seinfeld J; Sobrevilla A; Rosales ML; Ibáñez M; Ruiz D; Penny E; Londoño S
Expert Rev Pharmacoecon Outcomes Res; 2024 Jun; 24(5):661-669. PubMed ID: 38584495
[TBL] [Abstract][Full Text] [Related]
11. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
Köster I; Hauner H; von Ferber L
Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
[TBL] [Abstract][Full Text] [Related]
12. Exploring Different Strategies of Assessing the Economic Impact of Multiple Diabetes-Associated Complications and Their Interactions: A Large Claims-Based Study in Germany.
Kähm K; Laxy M; Schneider U; Holle R
Pharmacoeconomics; 2019 Jan; 37(1):63-74. PubMed ID: 30167918
[TBL] [Abstract][Full Text] [Related]
13. Societal Costs of First-Incident Ischemic Stroke in Patients with Atrial Fibrillation-A Danish Nationwide Registry Study.
Jakobsen M; Kolodziejczyk C; Fredslund EK; Poulsen PB; Dybro L; Johnsen SP
Value Health; 2016 Jun; 19(4):413-8. PubMed ID: 27325333
[TBL] [Abstract][Full Text] [Related]
14. Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
Javanbakht M; Baradaran HR; Mashayekhi A; Haghdoost AA; Khamseh ME; Kharazmi E; Sadeghi A
PLoS One; 2011; 6(10):e26864. PubMed ID: 22066013
[TBL] [Abstract][Full Text] [Related]
15. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications.
Zhuo X; Zhang P; Hoerger TJ
Am J Prev Med; 2013 Sep; 45(3):253-61. PubMed ID: 23953350
[TBL] [Abstract][Full Text] [Related]
16. Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden.
Andersson E; Persson S; Hallén N; Ericsson Å; Thielke D; Lindgren P; Steen Carlsson K; Jendle J
Diabetologia; 2020 Dec; 63(12):2582-2594. PubMed ID: 32968866
[TBL] [Abstract][Full Text] [Related]
17. Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses.
Alzaid A; Ladrón de Guevara P; Beillat M; Lehner Martin V; Atanasov P
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):785-798. PubMed ID: 32686530
[No Abstract] [Full Text] [Related]
18. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
[TBL] [Abstract][Full Text] [Related]
19. Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany.
Kähm K; Laxy M; Schneider U; Rogowski WH; Lhachimi SK; Holle R
Diabetes Care; 2018 May; 41(5):971-978. PubMed ID: 29348194
[TBL] [Abstract][Full Text] [Related]
20. The cost of treating type 2 diabetes (CODEIRE).
Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
